Revenue Breakdown
Composition ()
No data
Revenue Streams
Fresenius Medical Care AG (FMS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Care Delivery, accounting for 67.0% of total sales, equivalent to $3.83B. Other significant revenue streams include Care Enablement and Value based care. Understanding this composition is critical for investors evaluating how FMS navigates market cycles within the Healthcare Facilities & Services industry.
Profitability & Margins
Evaluating the bottom line, Fresenius Medical Care AG maintains a gross margin of 27.39%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.86%, while the net margin is 7.93%. These profitability ratios, combined with a Return on Equity (ROE) of 7.18%, provide a clear picture of how effectively FMS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, FMS competes directly with industry leaders such as EHC and GH. With a market capitalization of $13.77B, it holds a leading position in the sector. When comparing efficiency, FMS's gross margin of 27.39% stands against EHC's 90.23% and GH's 64.63%. Such benchmarking helps identify whether Fresenius Medical Care AG is trading at a premium or discount relative to its financial performance.
